type here...

CATEGORIES

Press Release

LATEST

Editors Choice

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Medika Life -
Editors Choice

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

Medika Life -
Editors Choice

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Medika Life -
Editors Choice

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

Medika Life -
Editors Choice

GE HealthCare and Biofourmis Collaborate to Extend Patient Monitoring Outside the Hospital with Virtual Care-at-Home Solutions

Medika Life -
Injury

Sheba Medical Center Selects Two Digital Startups for Integration into Newly Expanded Rehabilitation Ward

Medika Life -
Health Insurance

Benchmark KFF Survey: Annual Family Premiums for Employer Coverage Rise 7% to Nearly $24,000 in 2023

Medika Life -
Editors Choice

KFF Survey Shows Complexity, Red Tape, Denials, Confusion Rivals Affordability as a Problem for Insured Consumers, With Some Saying It Caused Them to Go...

Medika Life -
Editors Choice

Clinics IV Life Launches a New Clinic Model to Change the Face of Charitable Maternal Care, Delivery to Impoverished Communities

Robert Turner, Founding Editor -
Press Release

The Journal – Artificial Intelligence in the Life Sciences – Highlights the Contributions of Women in Artificial Intelligence in the Life Sciences

Medika Life -
123...12Page 1 of 12

TRENDING

EDITORS CHOICE

Digital Salutem Welcomes Gil Bashe and Stacy Hurt as Board Members

Medika Life -
Digital Salutem is delighted to announce that digital health influencers, Gil Bashe and Stacy Hurt, have joined ours team as board members

Evrysdi™ Approved for Spinal Muscular Atrophy Home Treatment

Medika Life -
The FDA has approved Evrysdi™ (risdiplam), the first at-home, orally administered treatment for spinal muscular atrophy in children and adults

Opdivo® Approved for the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Medika Life -
FDA Approved Opdivo demonstrated superior overall survival benefit compared to docetaxel or paclitaxel in ESCC Patients

St. Jude scientists identify possible COVID-19 treatment in the lab

Medika Life -
If validated, the discovery by St Jude scientists could offer real tools to deal with hyperinflammatory immune responses, one of the leading causes of death in Covid-19 infections

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories